Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
暂无分享,去创建一个
Lisa N Kinch | Nick V Grishin | Na Zhang | Yair Lotan | Somasekar Seshagiri | Thomas D. Wu | Ivan Pedrosa | Payal Kapur | James Brugarolas | Jeremy Stinson | Samuel Peña-Llopis | Joseph Guillory | Sherry Heldens | Marlena Jackson | Thomas D Wu | Jens Reeder | Eric W Stawiski | Zora Modrusan | N. Grishin | S. Durinck | I. Pedrosa | J. Brugarolas | S. Peña-Llopis | Andrea Pavía-Jiménez | L. Kinch | Y. Lotan | V. Margulis | A. Sagalowsky | Grégoire Pau | S. Seshagiri | N. Zhang | Z. Modrušan | Jens Reeder | B. Jaiswal | S. Heldens | J. Stinson | P. Haverty | Joseph Guillory | F. D. de Sauvage | Weiru Wang | Connie Ha | F. Sauvage | E. Stawiski | Subhra Chaudhuri | V. Janakiraman | Kanika Bajaj Pahuja | Thong T. Nguyen | Y. Chen | C. S. Rivers | J. Gehring | Vasantharajan Janakiraman | Subhra Chaudhuri | Gregoire Pau | Karen Toy | Weiru Wang | Celina Sanchez Rivers | Arthur Sagalowsky | Steffen Durinck | Peter M. Haverty | Haley Hill | Connie Ha | Karen Toy | Peter M Haverty | B. Chow | Andrea Pavía-Jiménez | Bijay S Jaiswal | Vanina Toffessi-Tcheuyap | Thong T Nguyen | Ying-Jiun Chen | Sadia Saleem | Corissa J Harris | Eboni Holloman | Haley M Hill | Bernard Chow | Julian S Gehring | Vitaly Margulis | Frederic J de Sauvage | S. Saleem | Payal Kapur | Vanina Toffessi-Tcheuyap | M. Jackson | Corissa J. Harris | E. Holloman | Marlena Jackson | Jeremy Stinson | Sherry Heldens | Samuel Peña-Llopis | Z. Modrusan
[1] C. Ahn,et al. Two case reports , 2017, Medicine.
[2] Lawrence A. Donehower,et al. The somatic genomic landscape of chromophobe renal cell carcinoma. , 2014, Cancer cell.
[3] M. McInnes,et al. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI) , 2014, European Radiology.
[4] Erika J. Thompson,et al. Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes , 2014, Clinical Cancer Research.
[5] F. Jordan,et al. The Pyruvate Dehydrogenase Complexes: Structure-based Function and Regulation* , 2014, The Journal of Biological Chemistry.
[6] R. Belmaker,et al. Inositol-Related Gene Knockouts Mimic Lithium’s Effect on Mitochondrial Function , 2011 .
[7] J. Brugarolas,et al. Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications , 2013, Nature Protocols.
[8] Lars Egevad,et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.
[9] Osamu Takeuchi,et al. Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP , 2013, The Journal of experimental medicine.
[10] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[11] A. Hakimi,et al. A clear picture of renal cell carcinoma , 2013, Nature Genetics.
[12] H. Aburatani,et al. Integrated molecular analysis of clear-cell renal cell carcinoma , 2013, Nature Genetics.
[13] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[14] J. Bellmunt,et al. Targeted therapies and the treatment of non-clear cell renal cell carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] G. Gyapay,et al. Germline BAP1 mutations predispose to renal cell carcinomas. , 2013, American journal of human genetics.
[16] C. Siegel. Re: Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. , 2013, The Journal of urology.
[17] N. Grishin,et al. A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma , 2013, Molecular Cancer Research.
[18] F. Palmieri. The mitochondrial transporter family SLC25: identification, properties and physiopathology. , 2013, Molecular aspects of medicine.
[19] Y. Nagashima,et al. Transition of organizational category on renal cancer. , 2013, Japanese journal of clinical oncology.
[20] J. Zucman‐Rossi,et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. , 2013, Journal of hepatology.
[21] M. Stratton,et al. Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.
[22] Keith T Flaherty,et al. Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] A. Jemal,et al. Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.
[24] S. Gabriel,et al. Analysis of 6,515 exomes reveals a recent origin of most human protein-coding variants , 2012, Nature.
[25] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[26] W. Linehan,et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. , 2012, The Journal of urology.
[27] L. Stein,et al. Annotating Cancer Variants and Anti-Cancer Therapeutics in Reactome , 2012, Cancers.
[28] Robert Gentleman,et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.
[29] L. Schwartz,et al. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. , 2012, Radiology.
[30] Melanie A. Huntley,et al. Recurrent R-spondin fusions in colon cancer , 2012, Nature.
[31] Matthew B. Callaway,et al. MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.
[32] P. Bühlmann,et al. Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome , 2012, BMC Cancer.
[33] Navdeep S. Chandel,et al. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.
[34] N. Grishin,et al. BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.
[35] A. Børresen-Dale,et al. Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.
[36] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[37] M. Papotti,et al. Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma , 2012, Virchows Archiv.
[38] P. Schirmacher,et al. Molecular heterogeneity of TFE3 activation in renal cell carcinomas , 2012, Modern Pathology.
[39] A. Imbard,et al. Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein. , 2011, Molecular genetics and metabolism.
[40] K. Brown,et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.
[41] Gang Wang,et al. Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α. , 2011, Cancer research.
[42] D. Fisher,et al. Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] S. Gamblin,et al. AMP-activated protein kinase: nature's energy sensor. , 2011, Nature chemical biology.
[44] Jill M Hagenkord,et al. Clinical genomics of renal epithelial tumors. , 2011, Cancer genetics.
[45] G. Tisone,et al. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. , 2011, Transplantation proceedings.
[46] A. Gonzalez-Perez,et al. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.
[47] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[48] Lincoln Stein,et al. Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..
[49] J. Babb,et al. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. , 2010, AJR. American journal of roentgenology.
[50] Jonathan W. Pillow,et al. POSTER PRESENTATION Open Access , 2013 .
[51] A. Young. Editorial Comment from Dr Young to Molecular pathology of renal oncocytoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.
[52] M. Yusenko. Molecular pathology of chromophobe renal cell carcinoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.
[53] A. Osunkoya. Editorial Comment to Molecular pathology of chromophobe renal cell carcinoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.
[54] M. Yusenko. Molecular pathology of renal oncocytoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.
[55] M. Picken. Editorial Comment from Dr Picken to Molecular pathology of renal oncocytoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.
[56] W. Linehan,et al. The genetic basis of kidney cancer: a metabolic disease , 2010, Nature Reviews Urology.
[57] W. Huber,et al. which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .
[58] Serban Nacu,et al. Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..
[59] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[60] Mingming Jia,et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer , 2009, Nucleic Acids Res..
[61] S. Swamy,et al. PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data , 2009, Biostatistics.
[62] B. Peters,et al. Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. , 2009, Cancer cell.
[63] A. Ribes,et al. PDH E1β deficiency with novel mutations in two patients with Leigh syndrome , 2009, Journal of Inherited Metabolic Disease.
[64] Robert Gentleman,et al. ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data , 2009, Bioinform..
[65] B. Kemp,et al. AMPK in Health and Disease. , 2009, Physiological reviews.
[66] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[67] Börje Ljungberg,et al. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas , 2009, BMC Cancer.
[68] Haixia Cheng,et al. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. , 2009, Cancer research.
[69] R. Dummer,et al. Novel MITF targets identified using a two‐step DNA microarray strategy , 2008, Pigment cell & melanoma research.
[70] H. Moch,et al. Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases , 2008, The American journal of surgical pathology.
[71] J. Zha,et al. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. , 2008, Cancer research.
[72] R. Dhir,et al. Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors , 2008, Modern Pathology.
[73] R. Tibshirani,et al. Spatial smoothing and hot spot detection for CGH data using the fused lasso. , 2008, Biostatistics.
[74] M. Ladanyi,et al. Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.
[75] F. Ross,et al. Regulation of AMP‐activated protein kinase by a pseudosubstrate sequence on the γ subunit , 2007 .
[76] S. Richard,et al. Mutations in BHD and TP53 genes, but not in HNF1β gene, in a large series of sporadic chromophobe renal cell carcinoma , 2006, British Journal of Cancer.
[77] Fabien Campagne,et al. Gene Expression Profiling Separates Chromophobe Renal Cell Carcinoma from Oncocytoma and Identifies Vesicular Transport and Cell Junction Proteins as Differentially Expressed Genes , 2006, Clinical Cancer Research.
[78] P. Zimmermann. The prevalence and significance of PDZ domain-phosphoinositide interactions. , 2006, Biochimica et biophysica acta.
[79] J. Schneider,et al. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2006, American journal of physiology. Heart and circulatory physiology.
[80] Ben J. Powell,et al. Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[81] G. Pfeifer. Mutagenesis at methylated CpG sequences. , 2006, Current topics in microbiology and immunology.
[82] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[83] B. Burwinkel,et al. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. , 2005, American journal of human genetics.
[84] D. Pearce,et al. Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1. , 2005, Biochemical and biophysical research communications.
[85] R Y Ball,et al. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .
[86] N. Copeland,et al. Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.
[87] Pablo Tamayo,et al. Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[88] W. Gerald,et al. Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. , 2002, Cancer cell.
[89] P. Bork,et al. Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.
[90] S. Henikoff,et al. Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.
[91] L. Schmidt,et al. Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto‐oncogene: Modeling studies , 2001, Proteins.
[92] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[93] R. Vink,et al. Hepatocellular carcinoma in glycogen storage disease type IV , 2000, Archives of disease in childhood.
[94] P. Cullen,et al. Molecular Cloning and Functional Characterization of a Human Homologue of Centaurin-α , 1999 .
[95] W. Linehan,et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas , 1999, Oncogene.
[96] S. Scherer,et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.
[97] P. Bugert,et al. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour , 1997, The Journal of pathology.
[98] S. Bonsib,et al. Papillary renal tumors. Morphologic, cytochemical, and genotypic features , 1995, Cancer.
[99] James A. Vaught,et al. microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. , 1994, Genes & development.
[100] E. Medico,et al. Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. , 1994, The Journal of biological chemistry.
[101] G. Corrent,et al. Metabolic disease , 2000, Dermatologic clinics.
[102] Robert C. Wolpert,et al. A Review of the , 1985 .
[103] R. Siegel,et al. Combined median and ulnar nerve lesions complicating fractures of the distal radius and ulna. Two case reports. , 1968 .
[104] Ann Allergy,et al. O R I G I N a L a R T I C L E S , 2022 .